Quick Answer
Voyager Therapeutics, Inc. reported Total Assets of $252.28 million for fiscal year 2025.
Voyager Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $252.28M | -35.8% |
| 2024 | $393.05M | +11.9% |
| 2023 | $351.28M | +120.4% |
| 2022 | $159.36M | -17.8% |
| 2021 | $193.85M | -25.9% |
| 2020 | $261.58M | -26.3% |
| 2019 | $354.76M | +100.4% |
| 2018 | $177.03M | -4.0% |
| 2017 | $184.48M | -2.7% |
| 2016 | $189.57M | -17.4% |
| 2015 | $229.46M | +1895.8% |
| 2014 | $11.50M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $288.31M | -32.3% | -10.5% |
| June 30, 2025 | $322.10M | -26.2% | -8.8% |
| March 31, 2025 | $353.24M | -24.8% | -10.1% |
| December 31, 2024 | $393.05M | +11.9% | -7.7% |
| September 30, 2024 | $426.04M | +44.6% | -2.3% |
| June 30, 2024 | $436.23M | +38.2% | -7.1% |
| March 31, 2024 | $469.59M | +39.6% | +33.7% |
| December 31, 2023 | $351.28M | +120.4% | +19.2% |
- Voyager Therapeutics, Inc. showed a decrease of -35.8% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, Voyager Therapeutics, Inc.’s total assets has grown by 2094.3% (from $11.50 million to $252.28 million).
- The most recent figure is from Voyager Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: